These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25070497)

  • 1. Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal disease.
    Ruebner RL; Reese PP; Abt PL
    Transpl Int; 2014 Dec; 27(12):1263-71. PubMed ID: 25070497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
    Selck FW; Grossman EB; Ratner LE; Renz JF
    Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
    Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
    Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of center volume on outcomes of increased-risk liver transplants.
    Ozhathil DK; Li YF; Smith JK; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    Liver Transpl; 2011 Oct; 17(10):1191-9. PubMed ID: 21604357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.
    Blok JJ; Braat AE; Adam R; Burroughs AK; Putter H; Kooreman NG; Rahmel AO; Porte RJ; Rogiers X; Ringers J; ;
    Liver Transpl; 2012 Jan; 18(1):112-9. PubMed ID: 21987454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury.
    Leithead JA; Tariciotti L; Gunson B; Holt A; Isaac J; Mirza DF; Bramhall S; Ferguson JW; Muiesan P
    Am J Transplant; 2012 Apr; 12(4):965-75. PubMed ID: 22226302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donation after cardiac death as a strategy to increase deceased donor liver availability.
    Merion RM; Pelletier SJ; Goodrich N; Englesbe MJ; Delmonico FL
    Ann Surg; 2006 Oct; 244(4):555-62. PubMed ID: 16998364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors.
    Chan EY; Olson LC; Kisthard JA; Perkins JD; Bakthavatsalam R; Halldorson JB; Reyes JD; Larson AM; Levy AE
    Liver Transpl; 2008 May; 14(5):604-10. PubMed ID: 18433032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
    Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
    Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving use of higher risk grafts is associated with an increased incidence of acute kidney injury after liver transplantation.
    Leithead JA; Rajoriya N; Gunson BK; Muiesan P; Ferguson JW
    J Hepatol; 2014 Jun; 60(6):1180-6. PubMed ID: 24631601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution.
    Sundaram V; Choi G; Jeon CY; Ayoub WS; Nissen NN; Klein AS; Tran TT
    Transplantation; 2015 May; 99(5):973-8. PubMed ID: 25340598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.
    Wadei HM; Bulatao IG; Gonwa TA; Mai ML; Prendergast M; Keaveny AP; Rosser BG; Taner CB
    Liver Transpl; 2014 Jun; 20(6):728-35. PubMed ID: 24648186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation.
    Ho KJ; Owens CD; Johnson SR; Khwaja K; Curry MP; Pavlakis M; Mandelbrot D; Pomposelli JJ; Shah SA; Saidi RF; Ko DS; Malek S; Belcher J; Hull D; Tullius SG; Freeman RB; Pomfret EA; Whiting JF; Hanto DW; Karp SJ
    Transplantation; 2008 Jun; 85(11):1588-94. PubMed ID: 18551064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.
    Pan X; Apinyachon W; Xia W; Hong JC; Busuttil RW; Steadman RH; Xia VW
    Liver Transpl; 2014 Jul; 20(7):823-30. PubMed ID: 24711100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
    Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
    Taner CB; Bulatao IG; Willingham DL; Perry DK; Sibulesky L; Pungpapong S; Aranda-Michel J; Keaveny AP; Kramer DJ; Nguyen JH
    Liver Transpl; 2012 Jan; 18(1):100-11. PubMed ID: 21837741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.